Sat.Jul 15, 2023 - Fri.Jul 21, 2023

article thumbnail

7 best practices for assessing eCOA technology solutions

pharmaphorum

7 best practices for assessing eCOA technology solutions Mike.

96
article thumbnail

Engaging Communities through High-Impact Healthcare Sponsorships in the Pharmaceutical Industry 

Pharma Marketing Network

Sponsorships can be a powerful tool for pharmaceutical companies to engage with communities and make a positive impact on health and wellness. When done right, sponsorships can help pharmaceutical companies connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. Here are some examples of how pharmaceutical companies can use sponsorships to engage communities: Sponsoring community health events: Pharmaceutical companies can s

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Community Pharmacy’s Next Mission: Closing Immunization Gaps Among Vulnerable and Underserved Populations

Pharmacy Times

Every pharmacist can make a difference in patients’ lives by taking the time to understand and fulfill the community’s social and cultural needs.

article thumbnail

Interventions Tailored to Race, Gender Could Help Decrease Drug Overdose Deaths

Drug Topics

Methamphetamine deaths among American Indian and Native Alaskan men and women significantly increased between 1992 and 2019.

187
187
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Patients Often Lose in the Battle Between Pharmaceutical Companies and PBMs

Drug Topics

Over the last 5 years, both PBMs and drug manufacturers have implemented restrictions that raise patients’ cost burden for specialty medications.

article thumbnail

How long should immune checkpoint inhibitor therapy be used in non-small cell lung cancer?

Hospital Pharmacy Europe

Immune checkpoint inhibitors have transformed the management of non-small cell lung cancer, but how long should treatment be continued for optimal survival? Rod Tucker takes a closer look at the evidence. It has long been recognised that a hallmark of cancer is immune evasion and that the immune system is held back by inhibitory immune checkpoint receptors and ligands.

More Trending

article thumbnail

Pure Oxygen Treatment May Significantly Improve Motor Learning Processes

Pharmacy Times

Study suggests supplemental oxygen may improve cognitive functions that are vital in motor learning, which can be important for people with neurological conditions or trauma.

123
123
article thumbnail

Therapeutic Drug Monitoring May Be Future of Inflammatory Bowel Disease Management

Pharmacy Times

Therapeutic drug monitoring is a growing and vital area for pharmacists to become involved in to increase patient success with inflammatory bowel disease remission.

123
123
article thumbnail

Medicare proposes broadening Alzheimer's brain scan coverage

Fierce Healthcare

The Centers for Medicare & Medicaid Services (CMS) could remove PET scan restrictions to better determine whether patients qualify for new drugs and to shine light on whether a drug is slowing | CMS could remove PET scan restrictions that limit just one brain scan per clinical trial to better determine whether new Alzheimer's drugs are slowing cognitive decline.

98
article thumbnail

The Senior Citizen Vote Is Feared With Good Reason

Drug Topics

Despite the increase in drug costs outpacing inflation, Pennsylvania seniors are still paying the same amount for prescriptions that they did in 1990.

186
186
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Misdiagnoses cost the U.S. 800,000 deaths and serious disabilities every year, study finds

STAT

Diagnostic errors — that is, overlooking a disease, or diagnosing it erroneously or late — are a known occurrence in health care, and one that can have tragic effects. Yet so far there have been few attempts to quantify misdiagnoses in terms of deaths and permanent disability, and the full scale of their impact has been underestimated by the medical community, according to a 2015 report by the National Academy of Medicine.

98
article thumbnail

Recommended Flu Vaccines for Older Adults

Pharmacy Times

An expert panel examines the distinctions among the 3 primary recommended flu vaccines for individuals aged 65 and above, assessing their efficacy compared with standard-dose flu vaccines.

Vaccines 123
article thumbnail

Regulators warn hospitals and telehealth companies about privacy risks of Meta, Google tracking tech

Fierce Healthcare

Federal regulators are warning hospital systems and telehealth providers about the data privacy risks of using third-party tracking technologies. | Federal regulators sent letters to 130 hospital systems and telehealth providers warning them about the data privacy and security risks related to the use of online tracking technologies integrated into their websites or mobile apps.

article thumbnail

DSCSA is Coming. Are you Ready?

Drug Topics

The Drug Supply Chain Security Act has been a decade in the making. Pharmacists must be prepared to comply by November 2023.

187
187
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

STAT+: White House launches permanent pandemic office

STAT

WASHINGTON – The White House on Friday launched its pandemic preparedness office, half a year after Congress instructed the administration to set up a new arm in the wake of the coronavirus pandemic. The Office of Pandemic Preparedness and Response Policy is a now-permanent installment in Washington and will first be led by retired Major General Paul Friedrichs, a longtime biosecurity official.

article thumbnail

Study Findings Urge Use of Personalized Hearing Aids for Older Individuals

Pharmacy Times

Individuals with age-related hearing loss should not be treated with “standard” hearing aids, but fitted to their personal needs, while avoiding settings that add distortion.

123
123
article thumbnail

After FDA snub, Daiichi's Vanflyta gains US approval and tees up AML clash with Novartis, Astellas

Fierce Pharma

If at first you don’t succeed, try, try again. That’s the lesson Daiichi Sankyo likely took home Friday after scoring a long-awaited U.S. | Some four years after Daiichi Sankyo's quizartinib scored its initial green light in Japan—and suffered a slap-down from drug regulators stateside—the acute myeloid leukemia medicine has won the FDA’s blessing.

FDA 98
article thumbnail

Monthly Buprenorphine Initiation Rates Remain Flat, Despite Policy Changes

Drug Topics

Only 1 in 5 patients who initiated buprenorphine were retained in therapy for at least 180 days.

187
187
article thumbnail

Providers still hesitate to prescribe buprenorphine for addiction, despite ‘X-waiver’ removal

STAT

Significant challenges remain before most American clinicians feel comfortable treating patients with buprenorphine , according to a new study. While the federal government’s recent moves to deregulate buprenorphine have led to a bump in new prescribers, it didn’t lead to a significant bump in overall prescribing volume. Many health care providers still see prescribing buprenorphine as difficult, or simply have little interest in using the medication, according to the study.

98
article thumbnail

Inflation Reduction Act, EOM, PBM Reform Remain Hot Topics on Capitol Hill

Pharmacy Times

Effective implementation of the Inflation Reduction Act may allow legislators to shift their focus toward controversial pharmacy benefit manager practices, according to a panel discussion during the ATOPP Summit.

123
123
article thumbnail

Providers improperly collected $784M from a fund for uninsured COVID patients. Now, the government wants it back

Fierce Healthcare

A pandemic program that distributed funds for uninsured patients’ COVID-19 testing and treatment made nearly $784 million in improper payments to healthcare providers, money the government should b | A recent audit estimated that COVID testing and treatment payments for millions of uninsured patients shouldn't have happened. The government agency responsible for the program says it's now working to claw those funds back from providers.

98
article thumbnail

Traveling With Daily Medications? Keep These Tips in Mind

Drug Topics

A Q&A with Colin Banas, MD, chief medical officer at health care software company DrFirst.

187
187
article thumbnail

Opinion: Gain-of-function research is about much more than dangerous pathogens

STAT

In the wake of the Covid-19 pandemic, we’ve heard a lot about gain-of-function research, and some of its risks, particularly regarding the possible creation of dangerous pathogens. But there’s a lot more to this field than that, including research that could potentially be quite beneficial to human society. If we focus solely on the risks, we may miss those benefits.

98
article thumbnail

Confirmatory PAPILLON Study Supports Amivantamab-vmjw For Patients with Severe Lung Cancer Mutation

Pharmacy Times

The 5-year survival rate for patients with exon 20 insertion EFGR mutation is 8% in the frontline setting, worse than the survival rate of the 2 most common types of EGFR mutations in patients with advanced or metastatic non-small cell lung cancer.

122
122
article thumbnail

FTC votes to withdraw previous guidance around PBMs as probe continues

Fierce Healthcare

As it continues a broad probe into the operations of pharmacy benefit managers, the Federal Trade Commission has voted to rescind longstanding advocacy statements on this sector. | As it continues a broad probe into the operations of pharmacy benefit managers, the Federal Trade Commission has voted to rescind longstanding advocacy statements on this sector.

98
article thumbnail

Four Simple Steps to Turn a Pharmacy’s Front End Into a Profit Magnet

Drug Topics

Filling prescriptions is no longer a sufficient source of revenue for community pharmacy.

article thumbnail

Opinion: Stanford President Marc Tessier-Lavigne and the new standards of scientific conduct

STAT

Stanford President Marc Tessier-Lavigne , who will step down from his position Aug. 31, was initially accused of scientific misconduct, but that’s not why he lost his job. He lost it because he failed to adequately lead his labs, and because of the repercussions that failure had for his leadership of a premier research institution. In his own words, Tessier-Lavigne resigned because Stanford “needs a president whose leadership is not hampered” by discussions of problems with

98
article thumbnail

Search Engines Provide Higher Quality Information on HIV PrEP Compared to Virtual Assistants

Pharmacy Times

For adolescents and young adults affected by HIV, Google yielded higher quality information on pre-exposure prophylaxis more frequently compared to other search engines.

123
123
article thumbnail

Novo Nordisk, Eli Lilly and Boehringer Ingelheim back bill to bring obesity drug coverage to Medicare

Fierce Pharma

Despite the widespread hype surrounding new and powerful obesity medicines, the drugs are still out of reach for many Americans who could benefit. | Despite the widespread hype surrounding new and powerful obesity medicines, the drugs are still out of reach for many Americans who could benefit. A group of lawmakers is working to change that.

98
article thumbnail

What You Need to Know About the Albuterol Shortage

Drug Topics

The FDA is working quickly to address shortages of the form used in nebulizers.

FDA 187
article thumbnail

These factors could lead ACA plan premiums to rise next year: report

Fierce Healthcare

As the industry gears up for open enrollment to begin this fall, a new report offers a look into the major factors that could impact premium changes in the individual and small group markets. | As the industry gears up for open enrollment to begin this fall, a new report offers a look into the major factors that could impact premium changes in the individual and small group markets.

98
article thumbnail

Vitamin D Supplementation May Reduce Incidence of Cardiovascular Events

Pharmacy Times

Though the overall significance of the results were low, vitamin D was found to be especially useful in lowering the prevalence of myocardial infarction in older adults.

123
123
article thumbnail

STAT+: Damages from tornado at Pfizer plant could compound challenges of drug shortages

STAT

The tornado that struck parts of North Carolina on Wednesday not only damaged the immediate area, but could soon make it much harder for countless people across the U.S. and around the world to obtain needed medicines the next time they visit a hospital. Among the damaged buildings was a Pfizer plant in Rocky Mountain, N.C. that produces nearly 30% of all sterile injectable medicines that the company sells to U.S. hospitals.

article thumbnail

Sandoz doubles down on biosimilars with $90M Slovenia site where it plans to hire 200

Fierce Pharma

Sandoz is doubling down on its commitment to Slovenia in its globe-trotting biosimilar growth quest. | Sandoz is doubling down on its commitment to Slovenia in its globe-trotting biosimilar growth quest. Its latest move follows a separate $400 million pledge to build a plant in the country.

98